Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Recursion Pharmaceuticals, Inc. (RXRX)

Biohaven Ltd. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Biohaven Ltd. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.1B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against 56.2%. Biohaven Ltd. has the higher net margin (0.00% vs −697.1%) and the lower return on invested capital (−6,659.9% vs −88.5%). Across the 16 metrics below, Biohaven Ltd. leads on 10 and Recursion Pharmaceuticals, Inc. on 6.

Valuation

Metric BHVN RXRX Biotechnology median
P/E n/m n/m 10.26
P/S 2.13 27.93 9.18
P/B n/m 2.10 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.23 19.78 8.98
Earnings yield (27.50%) (25.62%) (34.89%)
Free cash flow yield (23.27%) (16.50%) (24.52%)

Profitability

Metric BHVN RXRX Biotechnology median
Gross margin 0.00% 29.21% 65.16%
Operating margin 0.00% (725.44%) 0.00%
Net margin 0.00% (697.13%) 0.00%
Free cash flow margin 0.00% (460.89%) 0.00%
Return on equity 940.46% (48.72%) (50.12%)
Return on assets (161.32%) (36.29%) (45.60%)
Return on invested capital (6,659.91%) (88.54%) 0.00%

Growth

Metric BHVN RXRX Biotechnology median
Revenue growth (TTM) 425.20% 56.18% 6.26%
EPS growth (last fiscal year) 26.08% 14.79% 29.88%
Revenue growth, 5-year CAGR — 79.91% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN RXRX Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 3.05 5.01 4.89
Net debt to EBITDA 0.11 1.31 1.01

Dividend

Metric BHVN RXRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BHVN RXRX Biotechnology median
Market cap 2.10b 2.18b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack